Vanguard Group Inc Tela Bio, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Tela Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 903,503 shares of TELA stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

903,503

Previous 903,503 -0.0%

Holding current value

$2.35 Million

Previous $4.25 Million 46.18%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.39 - $6.36 $450,190 - $652,211	-102,549 Reduced 10.19%	903,503 $4.25 Million
Q1 2024 May 10, 2024	BUY	$5.3 - $7.61 $38,154 - $54,784	7,199 Added 0.72%	1,006,052 $5.7 Million
Q4 2023 Feb 14, 2024	BUY	$4.5 - $7.51 $102,825 - $171,603	22,850 Added 2.34%	998,853 $6.61 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $10.68 $843,749 - $1.15 Million	107,484 Added 12.38%	976,003 $7.81 Million
Q2 2023 Aug 14, 2023	BUY	$9.23 - $11.23 $1.46 Million - $1.78 Million	158,152 Added 22.26%	868,519 $8.8 Million
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $330,592 - $422,637	35,132 Added 5.2%	710,367 $7.56 Million
Q4 2022 Feb 10, 2023	BUY	$6.5 - $11.5 $1.84 Million - $3.26 Million	283,667 Added 72.44%	675,235 $7.77 Million
Q1 2022 May 13, 2022	BUY	$11.35 - $13.7 $495,234 - $597,772	43,633 Added 12.54%	391,568 $4.55 Million
Q4 2021 Feb 14, 2022	SELL	$11.95 - $13.34 $72,106 - $80,493	-6,034 Reduced 1.7%	347,935 $4.45 Million
Q3 2021 Nov 12, 2021	BUY	$12.2 - $15.93 $142,605 - $186,205	11,689 Added 3.42%	353,969 $4.84 Million
Q2 2021 Aug 13, 2021	BUY	$11.7 - $16.11 $4 Million - $5.51 Million	342,280 New	342,280 $5.51 Million

Others Institutions Holding TELA

# of Institutions

Shares Held

18.3M

Call Options Held

759K

Put Options Held

100

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $49.8M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Tela Bio, Inc. Transaction History